About Dr Vasileios Kouranos

Consultant Respiratory Physician

Lung Health

Sub-specialties: Interstitial Lung Diseases, Respiratory Medicine, Pulmonary Fibrosis, Sarcoidosis, Breathlessness, Acute and chronic cough, General Respiratory Medicine, Cardiac Sarcoidosis, post-covid-lung-disease, connective-tissue-disease-related-lung-diseases.

Dr. Vasilis Kouranos is Consultant Respiratory Physician at Here at OneWelbeck as well as Royal Brompton Hospital with expertise in interstitial lung disease and sarcoidosis. He has strong clinical and academic interest in the risk stratification of interstitial lung disease and sarcoidosis.

Overview

Bookings: bookings.lunghealth@onewelbeck.com

Tel: 020 3653 2006

Dr. Vasilis Kouranos is Consultant Respiratory Physician at Here at OneWelbeck as well as Royal Brompton Hospital with expertise in interstitial lung disease and sarcoidosis. He has strong clinical and academic interest in the risk stratification of interstitial lung disease and sarcoidosis.

Areas of Expertise

Dr. Vasilis Kouranos performs a range of diagnostics, including:

  • All general respiratory conditions
  • lung diseases
  • Idiopathic pulmonary fibrosis (IPF)
  • Sarcoidosis
  • Cardiac sarcoidosis
  • Hypersensitivity pneumonitis
  • Connective tissue disease (such as scleroderma and rheumatoid arthritis) -related lung disease, Post-COVID lung disease, and respiratory complications

Sub-specialities:

About Dr Vasileios Kouranos

Dr Vasilis Kouranos is a consultant respiratory physician who is experienced in managing all respiratory conditions with specialist expertise in interstitial lung disease and sarcoidosis.
He works as an NHS consultant in the Royal Brompton Hospital, a highly specialised heart and lung hospital considered as the National centre of excellence for patients with lung disease in the UK.
Dr Vasileios Kouranos is an Honorary Clinical Senior Lecturer at Imperial College London. He is an active research investigator in clinical trials in the field of interstitial lung disease and sarcoidosis. Dr Kouranos continues to be highly active in clinical research focusing on the risk stratification and outcome of interstitial lung disease and sarcoidosis. He is supervising MSc and PhD students and publishing his research in the most prestigious medical journals.
He has completed his PhD on the role of cardiac MRI in screening general sarcoidosis population for cardiac involvement. He has developed the Cardiac Sarcoidosis Registry at the Royal Brompton hospital which is currently the largest in the world.

Reviews

Additional Information

Memberships:

  • WASOG
  • ERS
  • ATS
  • BTS

Clinical Posts:

  • Consultant Respiratory Physician at Royal Brompton Hospital

Awards:

  • Hellenic Thoracic Society Research award in 2011

Research Highlights

1. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
Savale L, Huitema M, Shlobin O, Kouranos V, Nathan SD, Nunes H, Gupta R, Grutters JC, Culver DA, Post MC, Ouellette D, Lower EE, Al-Hakim T, Wells AU, Humbert M, Baughman RP.
Eur Respir Rev. 2022 Feb 9;31(163):210165. doi: 10.1183/16000617.0165-2021.
2. BTS Clinical Statement on pulmonary sarcoidosis.
Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho LP, Kouranos V, Patterson K, Screaton NJ, Whight J, Wells AU.
Thorax. 2021 Jan;76(1):4-20. doi: 10.1136/thoraxjnl-2019-214348.
3. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features.
Kouranos V, Ward S, Kokosi MA, Castillo D, Chua F, Judge EP, Thomas S, Van Tonder F, Devaraj A, Nicholson AG, Maher TM, Renzoni EA, Wells AU.
Chest. 2020 Nov;158(5):2007-2014. doi: 10.1016/j.chest.2020.04.074.
4. Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact.
Bonifazi M, Sverzellati N, Negri E, Jacob J, Egashira R, Moser J, Piciucchi S, Mei F, De Lauretis A, Visca D, Goh N, Bonini M, Cirilli L, La Vecchia C, Chua F, Kouranos V, Margaritopoulos G, Kokosi M, Maher TM, Gasparini S, Gabrielli A, Wells AU, Renzoni EA.
Eur Respir J. 2020 Jul 9;56(1):1902135.
5. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
Shlobin OA, Kouranos V, Barnett SD, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Lower EE, Engel PJ, Wort J, Price L, Wells AU, Nathan SD, Baughman RP.
Eur Respir J. 2020 May 14;55(5):1901747.

Dr Vasileios Kouranos

Areas of Expertise

About Dr Vasileios Kouranos

Reviews

Additional Information

Research Highlights

Awards recieved